A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
EvolveImmune United, Inc
EvolveImmune United, Inc
OncoC4, Inc.
Sotio Biotech Inc.
Novartis
Incyte Corporation
Sumitomo Pharma America, Inc.
Shattuck Labs, Inc.
Gene Surgery LLC
Shanghai Bovax Biotechnology Co., Ltd.
Corregene Biotechnology Co., Ltd
HRYZ Biotech Co.
HRYZ Biotech Co.
Xencor, Inc.
Beijing Health Guard Biotechnology, Inc
Rubius Therapeutics
Xencor, Inc.
Genocea Biosciences, Inc.
Corregene Biotechnology Co., Ltd
Antiva Biosciences
Antiva Biosciences
Oryx GmbH & Co. KG
Eli Lilly and Company
Mannkind Corporation
Light Sciences LLC